These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8243521)

  • 1. The platelet angiotensin II receptor in type I diabetes: studies in patients with and without nephropathy.
    Makarious M; Pawlak M; Campbell LV; Timmermans V; Duggan K; Charlesworth JA; Macdonald GJ
    Eur J Clin Invest; 1993 Sep; 23(9):517-21. PubMed ID: 8243521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormality of the glomerular angiotensin II receptor in experimental diabetic nephropathy.
    Makarious M; Duggan K; Charlesworth JA; Macdonald GJ
    Clin Exp Pharmacol Physiol; 1993 May; 20(5):348-50. PubMed ID: 8324923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association of angiotensin II type 1 receptor gene polymorphism with diabetic nephropathy in insulin-dependent diabetes mellitus.
    Chowdhury TA; Dyer PH; Kumar S; Gough SC; Gibson SP; Rowe BR; Smith PR; Dronsfield MJ; Marshall SM; Mackin P; Dean JD; Morris PJ; Davies S; Dunger DB; Boulton AJ; Barnett AH; Bain SC
    Diabet Med; 1997 Oct; 14(10):837-40. PubMed ID: 9371475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet Na+/H+ antiport activity in patients with insulin-dependent diabetes mellitus with and without diabetic nephropathy.
    Düsing R; Sorger M; Mattes L; Göbel BO; Hoffmann G; Rosskopf D; Vetter H; Siffert W
    Clin Investig; 1993 Feb; 71(2):119-25. PubMed ID: 8384910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced number of angiotensin II receptors on platelets in insulin-dependent diabetes.
    Connell JM; Ding YA; Fisher BM; Frier BM; Semple PF
    Clin Sci (Lond); 1986 Aug; 71(2):217-20. PubMed ID: 3013490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The angiotensin II inhibition escape phenomenon in patients with type 2 diabetes and diabetic nephropathy].
    Shamkhlova MSh; Trubitsyna NP; Katsaia GV; Goncharov NP; Malysheva NM; Il'in AV; Nikankina LV; Koshel' LV; Shestakova MV
    Ter Arkh; 2008; 80(1):49-52. PubMed ID: 18326228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity.
    Tarnow I; Michelson AD; Barnard MR; Frelinger AL; Aasted B; Jensen BR; Parving HH; Rossing P; Tarnow L
    Platelets; 2009 Nov; 20(7):513-9. PubMed ID: 19852691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients.
    Tarnow L; Cambien F; Rossing P; Nielsen FS; Hansen BV; Lecerf L; Poirier O; Danilov S; Parving HH
    Diabetes; 1995 May; 44(5):489-94. PubMed ID: 7729604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of platelet-lymphocyte aggregation in circulating blood of patients with type 1 diabetes with and without diabetic nephropathy.
    Vitkovsky Y; Kuznik B; Solpov A; Magen E
    Isr Med Assoc J; 2008 Oct; 10(10):691-4. PubMed ID: 19009947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.
    Tarnow L; Rossing P; Nielsen FS; Hansen BV; Dyerberg J; Parving HH
    Diabetes Care; 1996 Dec; 19(12):1382-7. PubMed ID: 8941468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy.
    Tarnow L; Cambien F; Rossing P; Nielsen FS; Hansen BV; Ricard S; Poirer O; Parving HH
    Nephrol Dial Transplant; 1996 Jun; 11(6):1019-23. PubMed ID: 8671962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].
    Lehmann R; Spinas GA
    Praxis (Bern 1994); 1995 Oct; 84(44):1265-71. PubMed ID: 7491450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.
    Wysocki J; Ye M; Khattab AM; Fogo A; Martin A; David NV; Kanwar Y; Osborn M; Batlle D
    Kidney Int; 2017 Jun; 91(6):1336-1346. PubMed ID: 27927599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control.
    Barnas U; Schmidt A; Illievich A; Kiener HP; Rabensteiner D; Kaider A; Prager R; Abrahamian H; Irsigler K; Mayer G
    Diabetologia; 1997 Mar; 40(3):327-31. PubMed ID: 9084972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.
    Hovind P; Tarnow L; Oestergaard PB; Parving HH
    Kidney Int Suppl; 2000 Apr; 75():S56-61. PubMed ID: 10828763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
    Zimmermann J; Schramm L; Wanner C; Mulzer E; Henrich HA; Langer R; Heidbreder E
    Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDL subclasses in IDDM patients: relation to diabetic nephropathy.
    Lahdenperä S; Groop PH; Tilly-Kiesi M; Kuusi T; Elliott TG; Viberti GC; Taskinen MR
    Diabetologia; 1994 Jul; 37(7):681-8. PubMed ID: 7958539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension in insulin-dependent diabetes.
    Norgaard K
    Dan Med Bull; 1996 Feb; 43(1):21-38. PubMed ID: 8906979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial factors determine the development of diabetic nephropathy in patients with IDDM.
    Quinn M; Angelico MC; Warram JH; Krolewski AS
    Diabetologia; 1996 Aug; 39(8):940-5. PubMed ID: 8858216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.